October 2, 2015
Pfizer acquisition of GlaxoSmithKline’s vaccines Nimenrix and Mencevax
Pfizer Inc. has announced that it has completed the acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax.